Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancer

20 Jul 2023

Abstract excerpt

The present study explored the clinical value of the protein expression levels of nucleotide binding oligomerization-like receptor family pyrin domain containing 1 (NLRP1) and nucleotide-binding oligomerization domain leucine-rich repeat and caspase recruitment domain-containing 4 (NLRC4) inflammasomes in the diagnosis and treatment of prostate cancer. A total of 54 patients with prostatic hyperplasia and 58...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gout, Hyperuricemia, Uric Acid
Share to Inflammasome and immune disorders
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37559581
DOI: 10.3892/ol.2023.13971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancerPMID 37559581Read ↗

Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer.Semantic proximity Read ↗

Preliminary study on miRNA in prostate cancerSemantic proximity Read ↗

Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis‐Related Signature in Localized Prostate CancerSemantic proximity Read ↗

The NLRP1 inflammasome emerges as a promising therapeutic target and prognostic biomarker across multiple cancer types: A comprehensive pan-cancer analysisSemantic proximity Read ↗

Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.Semantic proximity Read ↗

Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study.Semantic proximity Read ↗

Predictors of Symptom Severity and Predictive Performance of Immune- Inflammation Indices Levels in Patients with Benign Prostatic Hyperplasia attending Dessie Comprehensive Specialized HospitalSemantic proximity Read ↗

LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population.Semantic proximity Read ↗

Identification and functional activity of Nik related kinase (NRK) in benign hyperplastic prostateSemantic proximity Read ↗

NLRP2 in health and diseaseSemantic proximity Read ↗

Plasma metabolites as mediators in the relationship between inflammation-related proteins and benign prostatic hyperplasia: insights from mendelian randomization.Semantic proximity Read ↗

Caspase-Linked Programmed Cell Death in Prostate Cancer: From Apoptosis, Necroptosis, and Pyroptosis to PANoptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.